This page was translated automatically from Turkish. Read the original
← Back to blogADHD medications do not cause addiction — on the contrary, they may prevent it.
US data from 3 million patients (Quinn et al., American Journal of Psychiatry 2017): during periods of ADHD medication use, substance-related emergency department visits decreased by 35% in men and 31% in women. The protective effect persists even 2 years after treatment ends.
Swedish national registry data (Chang et al., 2014; n=38,753): substance misuse was 31% lower among those taking prescribed stimulants. A target trial analysis published in BMJ in 2025 (Zhang et al.; n=148,581): starting ADHD medication reduces substance misuse by 15%, suicidal behavior by 17%, and criminal behavior by 13%.
The mechanistic explanation (Volkow et al., 2003): orally administered stimulants raise dopamine levels in the brain SLOWLY — producing a therapeutic effect. With intranasal/intravenous administration, dopamine rises rapidly — producing an addictive effect. When used correctly at the prescribed dose, they not only pose no risk of addiction but are also protective.
The real risk is leaving ADHD untreated. Untreated ADHD increases the risk of addiction 2–6-fold. When the brain’s reward circuitry is underactive, a person turns to cigarettes, cannabis, alcohol, or cocaine — science calls this “self-medication.” JAMA Psychiatry 2015: in people with co-occurring ADHD and cocaine dependence, high-dose amphetamine treatment achieved a success rate 4 times higher than placebo.
Treatment decisions should be guided by evidence, not fear.